What abrdn Healthcare Opportunities Fund's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 568 |
| Disposed | 0 | 0 |
| Net activity | +0 | +568 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mahai Chris LaVictoire | Director | Jul 16 | Open-market buy · P | +568 | $18.49 | +$10.5K | 568 |
| DiMartino Rose | Director | Jul 16 | Open-market buy · P | +1,000 | $21.30 | +$21.3K | 1,000 |
| Goetz Kathleen | Director | Apr 09 | Open-market buy · P | +600 | $19.54 | +$11.7K | 1,148 |
| Reit Todd | Director | Jan 02 | Open-market buy · P | +1,000 | $18.44 | +$18.4K | 1,000 |
| Maher Bill | Director | Dec 28 | Open-market buy · P | +1,000 | $18.25 | +$18.3K | 1,000 |
| Goetz Kathleen | Director | Mar 23 | Open-market buy · P | +69 | $21.69 | +$1.5K | 548 |
| Goetz Kathleen | Director | Jan 26 | Open-market buy · P | +479 | $21.73 | +$10.4K | 479 |
| Reardon William S | Director | Feb 25 | Open-market buy · P | +1,196 | $20.85 | +$24.9K | 1,196 |
| Bailey Jeffrey Allen | Director | Sep 23 | Open-market buy · P | +570 | $17.68 | +$10.1K | 570 |
| Omstead Daniel R | President | Mar 17 | Open-market buy · P | +7,300 | $14.67 | +$107K | 31,202 |
| Omstead Daniel R | President | Oct 25 | Open-market buy · P | +6,000 | $17.43 | +$105K | 23,902 |
| Omstead Daniel R | President | Oct 17 | Open-market buy · P | +5,902 | $18.19 | +$107K | 17,902 |
| Omstead Daniel R | President | Oct 11 | Open-market buy · P | +5,500 | $17.59 | +$96.8K | 12,000 |
| Omstead Daniel R | President | Oct 10 | Open-market buy · P | +5,500 | $18.27 | +$100K | 6,500 |
| Kent Thomas M | Director | Jan 25 | Open-market buy · P | +1,400 | $18.50 | +$25.9K | 1,400 |
| Stebbins Lucinda H | Director | Dec 03 | Open-market buy · P | +1,000 | $20.07 | +$20.1K | 1,000 |
| Omstead Daniel R | President | Jul 28 | Open-market buy · P | +1,000 | $20.00 | +$20K | 1,000 |
| Bonney Michael W | Director | Jul 28 | Open-market buy · P | +5,000 | $20.00 | +$100K | 5,000 |
Loading...